TCL Archive ODAC votes 9-6 in favor of Clolar for pediatric acute lymphoblastic leukemia, but votes against Marqibo for non-Hodgkin’s lymphoma. December 10, 2004
TCL Archive Turnover In Immunology Contracts To Free Up Substantial Sums, Possible New RFPs Listed October 8, 1976
TCL Archive Chemosensitivity, Resistance Assays Not Ready For Clinic, ASCO Tech Assessment Says August 27, 2004
